Nano-X Imaging (NNOX) Financials: History & Chart

Nano-X Imaging Ltd.(NNOX)

Medical - Devices · Petah Tikva

$0.63-0.02 (-2.41%)

Delayed quote: Oct 6, 2026, 1:29 PM EDT

About Nano-X Imaging Ltd.

Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.

Petah Tikva

197 employees

www.nanox.vision

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Erez I. Meltzer

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	15.63M	4.16M	4.31M	3.72M	3.45M	3.04M	2.81M	3.00M	3.03M
Cost of Goods Sold	68.50M	47.83M	7.01M	7.34M	6.33M	6.28M	5.86M	5.89M	5.84M
Gross Profit	-52.87M	-43.67M	-2.70M	-3.62M	-2.88M	-3.24M	-3.05M	-2.89M	-2.81M
Gross Profit Margin	-338.2%	-1050.9%	-62.6%	-97.3%	-83.6%	-106.6%	-108.3%	-96.3%	-92.8%
Total Operating Expenses	49.52M	11.80M	12.09M	14.27M	11.35M	11.25M	11.04M	12.09M	11.33M
Research & Development	14.13M	4.71M	N/A	4.84M	4.59M	4.83M	4.98M	5.40M	4.75M
Selling, General & Administrative	29.40M	7.34M	7.40M	7.89M	6.76M	6.37M	6.08M	6.56M	6.60M
Operating Income (EBIT)	-102.39M	-55.48M	-14.79M	-17.88M	-14.23M	-14.49M	-14.09M	-14.97M	-14.14M
Operating Margin	-654.9%	-1334.9%	-343.1%	-480.9%	-413.0%	-476.7%	-500.5%	-499.2%	-466.5%
Income Before Tax (EBT)	-118.57M	-55.54M	-14.19M	-35.07M	-13.78M	-14.64M	-13.32M	-14.15M	-13.73M
Interest Income	1.18M	N/A	369K	351K	457K	N/A	765K	820K	404K
Interest Expense	N/A	N/A	N/A	N/A	N/A	149K	N/A	N/A	N/A
Other Income/Expense	-16.19M	-60K	601K	-17.18M	457K	-149K	765K	820K	406K
Net Income	-116.81M	-55.49M	-14.27M	-33.37M	-13.68M	-14.72M	-13.24M	-14.06M	-13.64M
Income Tax Expense	-1.76M	-51K	76K	-1.69M	-94K	82K	-86K	-94K	-94K
Net Profit Margin	-747.2%	-1335.1%	-330.9%	-897.4%	-397.0%	-484.3%	-470.3%	-468.7%	-450.0%
EBITDA	-90.94M	-52.66M	-11.97M	-15.04M	-11.28M	-11.54M	-11.15M	-12.04M	-11.21M
EBITDA Margin	-581.7%	-1267.1%	-277.7%	-404.3%	-327.2%	-379.7%	-396.0%	-401.3%	-369.8%
Depreciation & Amortization	11.44M	2.82M	2.82M	2.85M	2.96M	2.95M	2.94M	2.94M	2.93M
EPS Basic	-1.70	-0.79	-0.20	-0.50	-0.21	-0.23	-0.21	-0.23	-0.23
EPS Diluted	-1.70	-0.79	-0.20	-0.50	-0.21	-0.23	-0.21	-0.23	-0.23
Weighted Average Basic Shares	69.93M	69.93M	69.62M	67.06M	64.32M	63.91M	63.95M	60.14M	58.62M
Weighted Average Diluted Shares	69.93M	69.93M	69.62M	67.06M	64.32M	63.91M	63.95M	60.14M	58.62M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	13.02M	11.28M	9.90M	8.58M	1.30M	0.00	0.00	0.00
Cost of Goods Sold	25.81M	21.89M	16.50M	15.46M	2.82M	208K	53K	35K
Gross Profit	-12.79M	-10.61M	-6.59M	-6.88M	-1.51M	-208K	-53K	-35K
Gross Profit Margin	-98.2%	-94.0%	-66.6%	-80.2%	-116.0%	N/A	N/A	N/A
Total Operating Expenses	47.91M	46.14M	56.00M	72.33M	60.05M	43.92M	22.57M	1.90M
Research & Development	19.24M	20.18M	26.05M	26.51M	17.12M	9.21M	2.72M	672K
Selling, General & Administrative	27.10M	25.75M	28.39M	45.63M	41.74M	34.71M	19.85M	1.23M
Operating Income (EBIT)	-60.70M	-56.75M	-62.59M	-109.71M	-61.56M	-43.92M	-22.57M	-1.90M
Operating Margin	-466.2%	-502.9%	-631.9%	-1279.0%	-4720.7%	N/A	N/A	N/A
Income Before Tax (EBT)	-76.81M	-53.87M	-61.12M	-108.92M	-61.85M	-43.81M	-22.56M	-1.91M
Interest Income	1.42M	2.87M	1.65M	789K	N/A	108K	8K	N/A
Interest Expense	N/A	N/A	N/A	N/A	288K	N/A	N/A	5K
Other Income/Expense	-16.11M	2.87M	1.47M	-14.67M	-288K	108K	8K	-5K
Net Income	-75.02M	-53.52M	-60.78M	-105.24M	-61.80M	-43.50M	-22.55M	-1.91M
Income Tax Expense	-1.79M	-358K	-339K	-3.68M	-48K	0.00	0.00	5K
Net Profit Margin	-576.1%	-474.3%	-613.6%	-1226.9%	-4739.1%	N/A	N/A	N/A
EBITDA	-49.00M	-45.01M	-50.78M	-98.20M	-59.27M	-43.72M	-22.52M	-1.87M
EBITDA Margin	-376.3%	-398.9%	-512.7%	-1144.8%	-4544.9%	N/A	N/A	N/A
Depreciation & Amortization	11.70M	11.73M	11.81M	11.51M	2.29M	208K	53K	35K
EPS Basic	-1.16	-0.91	-1.08	-2.01	-1.28	-1.22	-0.49	-0.06
EPS Diluted	-1.16	-0.91	-1.08	-2.01	-1.28	-1.22	-0.49	-0.06
Weighted Average Basic Shares	64.79M	58.62M	56.37M	52.23M	48.22M	35.65M	45.72M	34.17M
Weighted Average Diluted Shares	64.79M	58.62M	56.37M	52.23M	48.22M	35.65M	45.72M	34.17M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.